Posted by Michael Wonder on 11 Apr 2024
Children and young adults to benefit after NICE recommends personalised immunotherapy to treat blood cancer be made routinely available on the NHS
11 April 2024 - Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia.
Children and young adults with a form of leukaemia that develops rapidly are set to benefit after NICE today recommended an innovative, life-extending treatment where the person’s own immune cells are modified to fight the cancer.
